Search Results - "Asensio, Ò"

Asthma diagnosis in infants and preschool children: a systematic review of clinical guidelines by Moral, L, Vizmanos, G, Torres-Borrego, J, Praena-Crespo, M, Tortajada-Girbés, M, Pellegrini, F J, Asensio, Ó

“…The definition and diagnosis of asthma are the subject of controversy that is particularly intense in the case of individuals in the first years of life, due…”
Get more information

197 Longitudinal assessment of Pseudomonas aeruginosa in children with cystic fibrosis. Differences with healthy infants by Valdesoiro-Navarrete, L, Espasa, M, Rodrigo, C, Domingo, C, Asensio, Ò, López, N, Bosque-García, M

Get full text

Effects of omalizumab in Aspergillus-associated airway disease by Pérez-de-Llano, L A, Vennera, M C, Parra, A, Guallar, J, Marin, M, Asensio, O, Ausin, P, Borderías, L, Fernández, C, Granel, C, Pérez-Pimiento, A, Rubio, M

Get more information

412 Spanish multicentre registry-based study on the phenotype of patients with cystic fibrosis carrying the V232D (c.695T>A) mutation by Pastor, M.D, Vazquez, C, Quintana-Gallego, M.E, Delgado, I, Carro, L. Máiz, Sanz, V, Aguilar, A, Girón-Moreno, R.M, Luna, C, Villa, J.R, Prados, C, Barrio, M.I, Gartner, S, Asensio, O, Escribano, A, Cols, M, Gómez, A, Pijoan, J.I

Get full text

Scuba diving in children: Physiology, risks and recommendations by Cilveti, R, Osona, B, Peña, J A, Moreno, L, Asensio, O

“…The increase in recreational scuba diving in recent years, including children, involves risks and the possibility of accidents. While legislation, conditions…”
Get full text

Chronic granulomatous disease in pediatric patients: 25 years of experience by Soler-Palacín, P, Margareto, C, Llobet, P, Asensio, O, Hernández, M, Caragol, I, Español, T

“…Chronic granulomatous disease (CGD) is an uncommon primary immune deficiency (affecting 1/200,000 newborn infants) caused by a defect in phagocyte production…”
Get more information

2 Next Generation Sequencing genotyping project in Spanish cystic fibrosis patients with uncharacterized CFTR mutations by Alonso, M.-J, Asensio, O, Baranda, F, Bousoño, C, Figuerola, J, Giron, R, Gartner, S, Prados, C, Salcedo, A, Solé, A

Get full text

425 The European cystic fibrosis patient registry in Spain: the long and winding road that leads to a National Registry Normal by Vázquez, C, Solé, A, Cortell, I, Quintana-Gallego, M.E, Delgado, I, Lamas, A, Sanz, V, Girón-Moreno, R.M, Luna, C, Villa, J.R, Barrio, M.I, Prados, C, Gartner, S, Asensio, O, Escribano, A, Cols, M, Pérez, E, Olveira, C, Mondéjar, P, Gutiérrez, J.R, Callejón, A, Pastor, M.D, Baranda, F

Get full text

Non-vacuum processing of CuIn1−xGaxSe2 solar cells on rigid and flexible substrates using nanoparticle precursor inks by Kapur, Vijay K., Bansal, Ashish, Le, Phucan, Asensio, Omar I.

“…A novel non-vacuum process in which water based inks formulated using nanoparticles of mixed oxides of Cu, In and Ga are used to deposit a precursor layer of…”
Get full text

143 Seasonality of Pseudomonas aeruginosa isolation in patients with cystic fibrosis by Vilella, M, Larramona, H, Bosque, M, Costa, J, Espasa, M, Valdesoiro, L, Asensio, O, Domingo, X, Guijarro, E

Get full text

20 Inconclusive diagnosis following newborn screening for cystic fibrosis (CF): clinical outcomes in 56 infants from three Spanish CF centres by Gartner, S, Casals, T, Marin, J.L, Rovira, S, Moreno, A, Asensio, O, Costa, J, de Mir, I, Torrent, A, Sacoto, G, Cols, M, Bosque, M

Get full text

Observational study of the safety of a cluster schedule for subcutaneous immunotherapy in a pediatric population by Peñas, A, García-González, M, Cruz, M J, Valdesoiro, L, Boot, J D, Larramona, H, Asensio, O, Grau, R, Costa, J, Bosque, M

Get full text

21 Genotype–phenotype correlation of CFTR p.Leu206Trp mutation in 22 paediatric and adult cystic fibrosis (CF) patients by Gartner, S, de Gracia, J, Alvarez, A, Casals, T, Rovira, S, Asensio, O, de Mir, I, Torrent, A, Bosque, M, Moreno, A

Get full text

Diagnosis and treatment of allergic rhinitis in children: results of the PETRA study by Ibero, M, Justicia, J L, Alvaro, M, Asensio, O, Domínguez, O, Garde, J, Sancha, J, Valero, A

“…Good control of allergic rhinitis (AR) in children is desirable because it is associated with diseases such as asthma. The aim of this analysis of the PETRA…”
Get more information

Buceo en la edad pediátrica: fisiología, riesgos y recomendaciones by Cilveti, R, Osona, B, Peña, J.A, Moreno, L, Asensio, O

“…Resumen Introducción El gran auge de la práctica recreativa del buceo en los últimos años, incluyendo a los niños, comporta riesgos y la posibilidad de…”
Get full text

Neonatal screening for cystic fibrosis in Cataluña, Spain: 10 years of experience by Gartner, S, Casals, T, Marin, J.L, Seculi, J.L, Asensio, O, Hernandez, J.L, Prats, R, Cobos, N

Get full text

Microbiology of the respiratory tract in cystic fibrosis patients diagnosed by neonatal screening: differences with healthy patients by Valdesoiro-Navarrete, L, Bosque, M, Rodrigo, C, López, N, Valiente, A, Asensio, O, Larramona, H, Domingo, Ch

Get full text

Home intravenous antibiotics for cystic fibrosis by Marco, T, Asensio, O, Bosque, M, de Gracia J, Serra, C

“…Recurrent endobronchial infection in cystic fibrosis requires treatment with intravenous antibiotics for several weeks, which is usually administered in…”
Get more information

20 years experience with newborn screening for cystic fibrosis in Catalonia by Argudo-Ramírez, A., López, R.M., Pajares, S., De Aledo-Castillo, J.M. González, Delgado, G., Ramón, E., Gartner, S., Cols, M., Asensio, O., Bádenas, C., Casals, T., Marín-Soria, J.L.

Get full text

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home by Gardulf, Ann, Nicolay, Uwe, Asensio, Oscar, Bernatowska, Ewa, Böck, Andreas, Costa-Carvalho, Beatriz T., Granert, Carl, Haag, Stefan, Hernández, Dolores, Kiessling, Peter, Kus, Jan, Matamoros, Nuria, Niehues, Tim, Schmidt, Sigune, Schulze, Ilka, Borte, Michael

“…A large number of children and adults with primary antibody deficiencies need lifelong IgG replacement therapy. It is mostly unknown what effect the choice of…”
Get full text